Metraipolis › archive › dc_95bdc953fd71

Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated… — Europe PMC PMID:41079672

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41079672
DOI: 10.34133/research.0915
License (as archived): solo-consultazione
Archived: 2026-11-09T11:02:50.455Z
SHA-256 of the archived text: 3346af5f59453178ab238205bc677ff00f68e0220c52625e1765a091a7dd0f44
Stable URL of this page: https://metraipolis.com/documento/dc_95bdc953fd71

How to cite

Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated… — Europe PMC PMID:41079672 — Europe PMC (en), https://europepmc.org/article/MED/41079672 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_95bdc953fd71 (Metraipolis archive dc_95bdc953fd71, sha256 3346af5f59453178ab238205bc677ff00f68e0220c52625e1765a091a7dd0f44)

BibTeX

@misc{dc95bdc953fd71,
  title = {Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated… — Europe PMC PMID:41079672},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41079672},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_95bdc953fd71; sha256 3346af5f59453178ab238205bc677ff00f68e0220c52625e1765a091a7dd0f44},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41079672. Agents can read the archived copy with the MCP tool read_document.